Related Experiment Video
Updated: Jun 3, 2026

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model
Published on: November 26, 2010
Metastasis suppressors: basic and translational advances
C Buchanan1, M A Lago Huvelle, M G Peters
1Research Area. Institute of Oncology Angel H. Roffo, University of Buenos Aires, Buenos Aires, Argentina.
Abstract:
Tumor metastasis is a main contributor to death in cancer patients. In the last years, a new class of molecules that reduces the metastatic propensity has been identified: metastasis suppressors. These proteins regulate multiple steps in the metastatic cascade, including cell invasion, survival in the vascular and lymphatic circulation, and colonization of distant organ sites. As a consequence, they are very important therapeutic targets. This review discusses our current understanding of metastasis suppressors and how this knowledge might be useful to improve the treatment of cancer patients.
Insights
Metastasis suppressors are proteins that inhibit cancer spread and are key therapeutic targets. Understanding these molecules offers new strategies to improve patient treatment outcomes and reduce cancer mortality.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Tumor metastasis is a primary cause of cancer-related deaths.
- Metastasis suppressors represent a novel class of molecules with the potential to reduce cancer spread.
Purpose of the Study:
- To review the current understanding of metastasis suppressors.
- To explore the therapeutic potential of metastasis suppressors in improving cancer treatment.
Main Methods:
- Literature review of metastasis suppressor functions.
- Analysis of the role of metastasis suppressors in the metastatic cascade.
Main Results:
- Metastasis suppressors regulate critical steps of metastasis, including cell invasion and colonization.
- These proteins are crucial for preventing cancer cell survival in circulation and at distant sites.
Conclusions:
- Metastasis suppressors are vital targets for developing new cancer therapies.
- Further research into metastasis suppressors can lead to improved clinical strategies for managing metastatic cancer.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer

